Alerts will be sent to your verified email
Verify Email
ERIS
|
Eris Lifesciences
|
Pfizer
|
Wockhardt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.74 % | 19.03 % | -3.51 % |
|
5yr Avg Net Profit Margin
|
22.76 % | 26.04 % | -4.28 % |
|
Price to Book
|
8.49 | 5.57 | 5.29 |
|
P/E
|
62.59 | 29.06 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-54.68 Days | 21.86 Days | -94.15 Days |
|
5yr Average Interest Coverage Ratio
|
66.44 | 185.18 | -0.43 |
|
5yr Avg ROCE
|
18.34 % | 23.84 % | -0.28 % |
|
5yr Avg Operating Profit Margin
|
34.43 % | 31.72 % | 5.03 % |
|
5 yr average Debt to Equity
|
0.46 | 0.0 | 0.56 |
|
5yr CAGR Net Profit
|
-0.19 % | 76.68 % | n/a |
|
5yr Average Return on Assets
|
12.4 % | 15.25 % | -1.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.83 % | 63.92 % | 49.09 % |
|
Share Pledged by Promoters
|
16.93 % | 0.0 | 15.64 % |
|
Change in Promoter Holding (3 Yrs)
|
2.53 % | 0.0 | -16.66 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
6.42 % | 4.53 % | 7.99 % |
|
Eris Lifesciences
|
Pfizer
|
Wockhardt
|
|---|